168 related articles for article (PubMed ID: 25034208)
1. HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.
So-Armah KA; Chang J; Alcorn C; Lo Re V; Baker JV; Tracy R; Butt AA; Agan BK; Rimland D; Gibert CL; Goetz MB; Oursler KK; Rodriguez-Barradas MC; Kuller LH; Brown ST; Stein JH; Skanderson M; Justice AC; Freiberg MS
Curr HIV Res; 2014; 12(1):50-9. PubMed ID: 25034208
[TBL] [Abstract][Full Text] [Related]
2. Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals.
Tate JP; Sterne JAC; Justice AC;
AIDS; 2019 Apr; 33(5):903-912. PubMed ID: 30649058
[TBL] [Abstract][Full Text] [Related]
3. An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
Tate JP; Justice AC; Hughes MD; Bonnet F; Reiss P; Mocroft A; Nattermann J; Lampe FC; Bucher HC; Sterling TR; Crane HM; Kitahata MM; May M; Sterne JA
AIDS; 2013 Feb; 27(4):563-72. PubMed ID: 23095314
[TBL] [Abstract][Full Text] [Related]
4. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.
Justice AC; Modur SP; Tate JP; Althoff KN; Jacobson LP; Gebo KA; Kitahata MM; Horberg MA; Brooks JT; Buchacz K; Rourke SB; Rachlis A; Napravnik S; Eron J; Willig JH; Moore R; Kirk GD; Bosch R; Rodriguez B; Hogg RS; Thorne J; Goedert JJ; Klein M; Gill J; Deeks S; Sterling TR; Anastos K; Gange SJ;
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):149-63. PubMed ID: 23187941
[TBL] [Abstract][Full Text] [Related]
5. Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.
Stapleton JT; Bennett K; Bosch RJ; Polgreen PM; Swindells S
HIV Clin Trials; 2007; 8(6):429-36. PubMed ID: 18042508
[TBL] [Abstract][Full Text] [Related]
6. Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy.
Premeaux TA; Javandel S; Hosaka KRJ; Greene M; Therrien N; Allen IE; Corley MJ; Valcour VG; Ndhlovu LC
Front Immunol; 2020; 11():1321. PubMed ID: 32695109
[TBL] [Abstract][Full Text] [Related]
7. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
[TBL] [Abstract][Full Text] [Related]
8. Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapy.
Blanco JR; Romero L; Ramalle-Gómara E; Metola L; Ibarra V; Sanz M; Oteo JA; Garcia A; Pérez-Martínez L
HIV Med; 2020 Jul; 21(6):358-364. PubMed ID: 31885153
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.
Novelli S; Delobel P; Bouchaud O; Avettand-Fenoel V; Fialaire P; Cabié A; Souala F; Raffi F; Catalan P; Weiss L; Meyer L; Goujard C
J Int AIDS Soc; 2020 Apr; 23(4):e25485. PubMed ID: 32333726
[TBL] [Abstract][Full Text] [Related]
10. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.
Ghehi C; Gabillard D; Moh R; Badje A; Kouamé GM; Oouttara E; Ahibo H; N'Takpé JB; Lecarrou J; Eholié SP; Anglaret X; Danel C
PLoS One; 2017; 12(6):e0177440. PubMed ID: 28582393
[TBL] [Abstract][Full Text] [Related]
11. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
[TBL] [Abstract][Full Text] [Related]
12. The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.
Towner WJ; Xu L; Leyden WA; Horberg MA; Chao CR; Tang B; Klein DB; Hurley LB; Quesenberry CP; Silverberg MJ
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):321-7. PubMed ID: 22343179
[TBL] [Abstract][Full Text] [Related]
13. Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.
Polgreen PM; Fultz SL; Justice AC; Wagner JH; Diekema DJ; Rabeneck L; Weissman S; Stapleton JT
HIV Med; 2004 May; 5(3):144-50. PubMed ID: 15139979
[TBL] [Abstract][Full Text] [Related]
14. Sex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare system.
Blackstock OJ; Tate JP; Akgün KM; Crystal S; Duggal M; Edelman EJ; Gibert CL; Gordon KS; Rimland D; Rodriguez-Barradas MC; Wang EA; Fiellin DA; Justice AC
J Gen Intern Med; 2013 Jul; 28 Suppl 2(Suppl 2):S577-82. PubMed ID: 23807068
[TBL] [Abstract][Full Text] [Related]
15. Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.
Kahler CW; Liu T; Cioe PA; Bryant V; Pinkston MM; Kojic EM; Onen N; Baker JV; Hammer J; Brooks JT; Patel P
AIDS Behav; 2017 Jul; 21(7):1825-1835. PubMed ID: 27392417
[TBL] [Abstract][Full Text] [Related]
16. Impact of HIV infection and HAART on serum lipids in men.
Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART.
Bedimo RJ; Mar H; Bosch RJ; Drechsler H; Cyktor JC; Macatangay BJC; Lalama C; Rinaldo C; Collier A; Godfrey C; Hogg E; Hensel C; Eron JJ; Mcmahon DK; Mellors JW; Tebas P; Gandhi RT;
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):e27-e31. PubMed ID: 31335587
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort.
Maggi P; Bellacosa C; Leone A; Volpe A; Ricci ED; Ladisa N; Cicalini S; Grilli E; Viglietti R; Chirianni A; Bellazzi LI; Maserati R; Martinelli C; Corsi P; Celesia BM; Sozio F; Angarano G
Atherosclerosis; 2017 Aug; 263():398-404. PubMed ID: 28522147
[TBL] [Abstract][Full Text] [Related]
19. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.
Chantry CJ; Hughes MD; Alvero C; Cervia JS; Meyer WA; Hodge J; Borum P; Moye J;
Pediatrics; 2008 Jul; 122(1):e129-38. PubMed ID: 18519448
[TBL] [Abstract][Full Text] [Related]
20. Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.
Salinas JL; Rentsch C; Marconi VC; Tate J; Budoff M; Butt AA; Freiberg MS; Gibert CL; Goetz MB; Leaf D; Rodriguez-Barradas MC; Justice AC; Rimland D
Clin Infect Dis; 2016 Dec; 63(11):1423-1430. PubMed ID: 27539575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
